by rdbiomed | Jan 23, 2020 | LPR
A new UK study with more than 1,000 patients has demonstrated how Peptest can be used to diagnose laryngopharyngeal reflux (LPR) in hospitals, voice clinics and GP surgeries. LPR is a condition responsible for up to 10 per cent of all otolaryngology (ear, nose and... 
by rdbiomed | Nov 28, 2019 | Company News
Let’s introduce you to a key member of the RD Biomed and Peptest team… Jeanine Fisher. Jeanine joined our company in 2006 and can usually be found in the Peptest laboratories at Castle Hill Hospital in Hull. As a Senior Laboratory Technician – and Project... 
by rdbiomed | Nov 25, 2019 | reflux treatments
Can chewing cashew gum help with your reflux symptoms? The most common current medicinal treatment for reflux symptoms focusses on the suppression of gastric acid using proton pump inhibitors (PPIs). However, recent studies have associated PPIs with serious side... 
by rdbiomed | Nov 21, 2019 | Company News
Peptest – a non-invasive device for diagnosing reflux disease – has been approved by Chinese health authorities and officially launched in China. The device detects the presence of pepsin (recognised as a diagnostic biomarker for reflux) in saliva samples. Leading... 
by rdbiomed | Nov 11, 2019 | LPR
Peptest has been described as a ‘cost‐effective, non-invasive measurement tool’ to assist office‐based diagnosis of laryngopharangeal reflux disease (LPR) in a new research paper. The study, published in The Laryngoscope – the monthly peer-reviewed medical...
Recent Comments